1
|
Medrano-Lopez JA, Villalpando I, Salazar MI, Torres-Torres C. Hierarchical Nanobiosensors at the End of the SARS-CoV-2 Pandemic. BIOSENSORS 2024; 14:108. [PMID: 38392027 PMCID: PMC10887370 DOI: 10.3390/bios14020108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/24/2023] [Revised: 02/09/2024] [Accepted: 02/15/2024] [Indexed: 02/24/2024]
Abstract
Nanostructures have played a key role in the development of different techniques to attack severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some applications include masks, vaccines, and biosensors. The latter are of great interest for detecting diseases since some of their features allowed us to find specific markers in secretion samples such as saliva, blood, and even tears. Herein, we highlight how hierarchical nanoparticles integrated into two or more low-dimensional materials present outstanding advantages that are attractive for photonic biosensing using their nanoscale functions. The potential of nanohybrids with their superlative mechanical characteristics together with their optical and optoelectronic properties is discussed. The progress in the scientific research focused on using nanoparticles for biosensing a variety of viruses has become a medical milestone in recent years, and has laid the groundwork for future disease treatments. This perspective analyzes the crucial information about the use of hierarchical nanostructures in biosensing for the prevention, treatment, and mitigation of SARS-CoV-2 effects.
Collapse
Affiliation(s)
- Jael Abigail Medrano-Lopez
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Ingeniería y Eléctrica, Unidad Zacatenco, Instituto Politécnico Nacional, Mexico City 07738, Mexico
| | - Isaela Villalpando
- Centro de Investigación para los Recursos Naturales, Salaices 33941, Mexico
| | - Ma Isabel Salazar
- Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11340, Mexico
| | - Carlos Torres-Torres
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Ingeniería y Eléctrica, Unidad Zacatenco, Instituto Politécnico Nacional, Mexico City 07738, Mexico
| |
Collapse
|
2
|
Horvath D, Basler M. PLGA Particles in Immunotherapy. Pharmaceutics 2023; 15:pharmaceutics15020615. [PMID: 36839937 PMCID: PMC9965784 DOI: 10.3390/pharmaceutics15020615] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 02/06/2023] [Accepted: 02/07/2023] [Indexed: 02/16/2023] Open
Abstract
Poly(lactic-co-glycolic acid) (PLGA) particles are a widely used and extensively studied drug delivery system. The favorable properties of PLGA such as good bioavailability, controlled release, and an excellent safety profile due to the biodegradable polymer backbone qualified PLGA particles for approval by the authorities for the application as a drug delivery platform in humas. In recent years, immunotherapy has been established as a potent treatment option for a variety of diseases. However, immunomodulating drugs rely on targeted delivery to specific immune cell subsets and are often rapidly eliminated from the system. Loading of PLGA particles with drugs for immunotherapy can protect the therapeutic compounds from premature degradation, direct the drug delivery to specific tissues or cells, and ensure sustained and controlled drug release. These properties present PLGA particles as an ideal platform for immunotherapy. Here, we review recent advances of particulate PLGA delivery systems in the application for immunotherapy in the fields of allergy, autoimmunity, infectious diseases, and cancer.
Collapse
Affiliation(s)
- Dennis Horvath
- Division of Immunology, Department of Biology, University of Konstanz, D-78457 Konstanz, Germany
- Centre for the Advanced Study of Collective Behaviour, University of Konstanz, D-78457 Konstanz, Germany
| | - Michael Basler
- Division of Immunology, Department of Biology, University of Konstanz, D-78457 Konstanz, Germany
- Biotechnology Institute Thurgau (BITg) at the University of Konstanz, CH-8280 Kreuzlingen, Switzerland
- Correspondence:
| |
Collapse
|
3
|
Chiechio RM, Ducarre S, Marets C, Dupont A, Even-Hernandez P, Pinson X, Dutertre S, Artzner F, Musumeci P, Ravel C, Faro MJL, Marchi V. Encapsulation of Luminescent Gold Nanoclusters into Synthetic Vesicles. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:nano12213875. [PMID: 36364651 PMCID: PMC9655092 DOI: 10.3390/nano12213875] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Revised: 10/24/2022] [Accepted: 10/26/2022] [Indexed: 06/02/2023]
Abstract
Gold nanoclusters (Au NCs) are attractive luminescent nanoprobes for biomedical applications. In vivo biosensing and bioimaging requires the delivery of the Au NCs into subcellular compartments. In this view, we explore here the possible encapsulation of ultra-small-sized red and blue emitting Au NCs into liposomes of various sizes and chemical compositions. Different methods were investigated to prepare vesicles containing Au NCs in their lumen. The efficiency of the process was correlated to the structural and morphological aspect of the Au NCs' encapsulating vesicles thanks to complementary analyses by SAXS, cryo-TEM, and confocal microscopy techniques. Cell-like-sized vesicles (GUVs) encapsulating red or blue Au NCs were successfully obtained by an innovative method using emulsion phase transfer. Furthermore, exosome-like-sized vesicles (LUVs) containing Au NCs were obtained with an encapsulation yield of 40%, as estimated from ICP-MS.
Collapse
Affiliation(s)
- Regina M. Chiechio
- Institut des Sciences Chimiques de Rennes, CNRS UMR 6226, Université Rennes 1, F-35000 Rennes, France
- Dipartimento di Fisica e Astronomia “Ettore Majorana”, Università Di Catania, Via Santa Sofia 64, 95123 Catania, Italy
- IMM-CNR, Via S. Sofia 64, 95123 Catania, Italy
| | | | - Célia Marets
- Institut des Sciences Chimiques de Rennes, CNRS UMR 6226, Université Rennes 1, F-35000 Rennes, France
| | - Aurélien Dupont
- BIOSIT, Inserm, CNRS UMS 3480, Université Rennes1, US_S 018, F-35000 Rennes, France
| | - Pascale Even-Hernandez
- Institut des Sciences Chimiques de Rennes, CNRS UMR 6226, Université Rennes 1, F-35000 Rennes, France
| | - Xavier Pinson
- Microscopy Rennes Imaging Centre, SFR Biosit, CNRS UMS 3480—US INSERM 018, Université Rennes 1, F-35000 Rennes, France
| | - Stéphanie Dutertre
- Microscopy Rennes Imaging Centre, SFR Biosit, CNRS UMS 3480—US INSERM 018, Université Rennes 1, F-35000 Rennes, France
| | - Franck Artzner
- Institut de Physique, CNRS UMR 6251, Université Rennes 1, F-35000 Rennes, France
| | - Paolo Musumeci
- Dipartimento di Fisica e Astronomia “Ettore Majorana”, Università Di Catania, Via Santa Sofia 64, 95123 Catania, Italy
| | - Célia Ravel
- Service de Biologie de la Reproduction-CECOS, CHU Rennes, F-35000 Rennes, France
- Irset (Institut de Recherche en Santé, Environnement et Travail), Inserm, EHESP, Université Rennes 1, F-35000 Rennes, France
| | - Maria Jose Lo Faro
- Dipartimento di Fisica e Astronomia “Ettore Majorana”, Università Di Catania, Via Santa Sofia 64, 95123 Catania, Italy
- IMM-CNR, Via S. Sofia 64, 95123 Catania, Italy
| | - Valérie Marchi
- Institut des Sciences Chimiques de Rennes, CNRS UMR 6226, Université Rennes 1, F-35000 Rennes, France
| |
Collapse
|
4
|
Kalangi SK, Bhosale R. Editorial: New Approaches in Toxicity Testing of Nanotherapeutics. Front Pharmacol 2022; 13:922551. [PMID: 35865959 PMCID: PMC9295594 DOI: 10.3389/fphar.2022.922551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2022] [Accepted: 05/06/2022] [Indexed: 11/13/2022] Open
Affiliation(s)
- Suresh K. Kalangi
- Amity Stem Cell Institute, Amity Medical School, Amity University Gurugram, Amity Education Valley, Gurugram, India
- *Correspondence: Suresh K. Kalangi, , orcid.org/0000-0002-7328-9322
| | - Rajesh Bhosale
- Department of Chemistry, School of Science, Indrashil University, Rajpur, India
| |
Collapse
|
5
|
Ghasemzad M, Hashemian SMR, Memarnejadian A, Akbarzadeh I, Hossein-Khannazer N, Vosough M. The nano-based theranostics for respiratory complications of COVID-19. Drug Dev Ind Pharm 2021; 47:1353-1361. [PMID: 34666567 DOI: 10.1080/03639045.2021.1994989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
High morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made coronavirus disease 2019 (COVID-19) the leading challenge for health experts all over the world. Currently, there is no specific treatment for COVID-19; however, thanks to worldwide intense attempts, novel vaccines such as mRNA-1273 (Moderna TX, Inc.) and BNT162b2 (Biontech/Pfizer) were developed very fast and FDA approved them for emergency use. Nanomedicine-based drug delivery can be an advanced therapeutic strategy to deal with clinical complications of COVID-19. Given the fact that SARS-CoV-2 typically affects the respiratory tract, application of inhalable nanoparticles (NPs) for targeted drug delivery to the alveolar space appears to be an effective and promising therapeutic strategy. Loading the medicinal components into NPs enhances the stability, bioavailability, solubility and sustained release of them. This approach can circumvent major challenges in efficient drug delivery such as solubility and any adverse impact of medicinal components due to off-targeted delivery and resulting systemic complications. Inhalable NPs could be delivered through nasal sprays, inhalers, and nebulizers. NPs also could interfere in virus attachment to host cells and prevent infection. Moreover, nanomedicine-based technologies can facilitate accurate and rapid detection of virus compared to the conventional methods. In this review, the nano-based theranostics modalities for the management of respiratory complications of COVID-19 were discussed.
Collapse
Affiliation(s)
- Mahsa Ghasemzad
- Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.,Faculty of Basic Sciences and Advanced Technologies in biology, Department of Molecular Cell Biology-Genetics, University of Science and Culture, Tehran, Iran.,Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Seyed Mohammad Reza Hashemian
- Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | | | - Iman Akbarzadeh
- Department of Chemical and Petrochemical Engineering, Sharif University of Technology, Tehran, Iran
| | - Nikoo Hossein-Khannazer
- Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.,Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Massoud Vosough
- Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
| |
Collapse
|
6
|
Safarchi A, Fatima S, Ayati Z, Vafaee F. An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection. Cell Biosci 2021; 11:164. [PMID: 34420513 PMCID: PMC8380468 DOI: 10.1186/s13578-021-00674-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Accepted: 08/03/2021] [Indexed: 12/24/2022] Open
Abstract
The ongoing pandemic of coronavirus disease 2019 (COVID-19) has made a serious public health and economic crisis worldwide which united global efforts to develop rapid, precise, and cost-efficient diagnostics, vaccines, and therapeutics. Numerous multi-disciplinary studies and techniques have been designed to investigate and develop various approaches to help frontline health workers, policymakers, and populations to overcome the disease. While these techniques have been reviewed within individual disciplines, it is now timely to provide a cross-disciplinary overview of novel diagnostic and therapeutic approaches summarizing complementary efforts across multiple fields of research and technology. Accordingly, we reviewed and summarized various advanced novel approaches used for diagnosis and treatment of COVID-19 to help researchers across diverse disciplines on their prioritization of resources for research and development and to give them better a picture of the latest techniques. These include artificial intelligence, nano-based, CRISPR-based, and mass spectrometry technologies as well as neutralizing factors and traditional medicines. We also reviewed new approaches for vaccine development and developed a dashboard to provide frequent updates on the current and future approved vaccines.
Collapse
Affiliation(s)
- Azadeh Safarchi
- School of Biotechnology and Biomolecular Science, University of New South Wales, NSW Sydney, Australia
| | - Shadma Fatima
- School of Biotechnology and Biomolecular Science, University of New South Wales, NSW Sydney, Australia
- Ingham Institute of Applied Medical Research, Liverpool, Australia
| | - Zahra Ayati
- Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- NICM Health Research Institute, Western Sydney University, Penrith, Australia
| | - Fatemeh Vafaee
- School of Biotechnology and Biomolecular Science, University of New South Wales, NSW Sydney, Australia
- UNSW Data Science Hub University of New South Wales, NSW Sydney, Australia
| |
Collapse
|